Envestnet Portfolio Solutions, Inc. Charles River Laboratories International, Inc. Transaction History
Envestnet Portfolio Solutions, Inc.
- $23.7 Billion
- Q1 2025
A detailed history of Envestnet Portfolio Solutions, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Envestnet Portfolio Solutions, Inc. holds 4,679 shares of CRL stock, worth $679,811. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,679
Previous 7,203
35.04%
Holding current value
$679,811
Previous $1.33 Million
47.03%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CRL
# of Institutions
648Shares Held
55MCall Options Held
695KPut Options Held
809K-
Vanguard Group Inc Valley Forge, PA6.11MShares$887 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$739 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$623 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$348 Million0.07% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.95MShares$283 Million0.75% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.39B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...